CSP welcomes regulatory body change to Dysport® licensing
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a product licence update for the botulinum toxin-A (BoNT-A) medicine Dysport® to make it clear that is can be administered by any appropriately trained and qualified healthcare professionals for the management of focal spasticity within licensed indications.
NICE outlines how organisations can help people be more active
The National Institute for Health and Care Excellence (NICE) has today detailed how local authorities, schools and workplaces can encourage physical activity.
Two CSP reps received awards at this year’s Annual Representative Conference, in recognition of their achievements making a difference in their respective workplaces.
CSP welcomes involvement in developing NHS People Plan for England
England’s Interim NHS People Plan, published today, sets out plans for 5,000 more physiotherapists for primary care networks, a commitment to developing advanced practice and to improving allied health profession supply. However, no new money has been committed.
The CSP has given a cautious welcome to several of the recommendations of the Augar Review on post-18 education and funding in England, published on 30 May.